Literature DB >> 23409695

Surgical management of Dupuytren's contracture in Europe: regional analysis of a surgeon survey and patient chart review.

J Dias1, C Bainbridge, C Leclercq, R A Gerber, D Guerin, J C Cappelleri, P P Szczypa, L B Dahlin.   

Abstract

AIM: We explored regional variations in the surgical management of patients with Dupuytren's contracture (DC) in 12 European countries using a surgeon survey and patient chart review.
METHODS: Twelve countries participated: Denmark, Finland, Sweden (Nordic region); Czech Republic, Hungary, Poland (East); France, Germany, the Netherlands, UK (West); Italy, Spain (Mediterranean). For the survey, a random sample of orthopaedic/plastic surgeons (n = 687) with 3-30 years' experience was asked about DC procedures performed during the previous 12 months. For the chart review (n = 3357), information from up to five consecutive patients was extracted. Descriptive statistics are reported.
RESULTS: Ninety-five per cent of all surgeons used fasciectomy for DC, followed by fasciotomy (70%), dermofasciectomy (38%) and percutaneous needle fasciotomy (35%). Most surgeons were satisfied with fasciectomy over other procedures. Recommended time away from work and duration of physical therapy increased with the invasiveness of the procedure. The intra-operative complication rate was 4.0%; the postoperative complication rate was 34%. Overall, ≥ 97% of the procedures were rated by surgeons as having a positive outcome. Across all regions, 54% of patients had no nodules or contracture after the procedures. Only 2% of patients required retreatment within the first year of surgery. Important inter- and intraregional differences in these aspects of patient management are described.
CONCLUSIONS: Understanding current regional treatment patterns and their relationships to country-specific health systems may facilitate earlier identification of, and intervention for, DD and help to optimise the overall treatment for patients with this chronic condition.
© 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23409695     DOI: 10.1111/ijcp.12106

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  6 in total

Review 1.  Collagenase Treatment in Dupuytren Contractures: A Review of the Current State Versus Future Needs.

Authors:  Ilse Degreef
Journal:  Rheumatol Ther       Date:  2016-02-03

Review 2.  Current role of the collagenase Clostridium histolyticum in Dupuytren's disease treatment.

Authors:  Rafael Sanjuan-Cervero
Journal:  Ir J Med Sci       Date:  2019-11-11       Impact factor: 1.568

3.  Cost-Effectiveness and Patient Outcomes of Injectable Collagenase to Treat Dupuytren's Contracture.

Authors:  Rajpreet S Sahemey; Govind S Dhillon; Karanjeet S Sagoo; Kuntrapaka Srinivas
Journal:  Cureus       Date:  2021-12-20

4.  Costs for collagenase injections compared with fasciectomy in the treatment of Dupuytren's contracture: a retrospective cohort study.

Authors:  Isam Atroshi; Emelie Strandberg; Anna Lauritzson; Eva Ahlgren; Markus Waldén
Journal:  BMJ Open       Date:  2014-01-15       Impact factor: 2.692

5.  Examiners' influence on the measured active and passive extension deficit in finger joints affected by Dupuytren disease.

Authors:  Jesper Nordenskjöld; Stina Brodén; Isam Atroshi
Journal:  BMC Med Res Methodol       Date:  2018-10-29       Impact factor: 4.615

6.  Collagenase injections for Dupuytren disease: 3-year treatment outcomes and predictors of recurrence in 89 hands.

Authors:  Jesper Nordenskjöld; Anna Lauritzson; Anna Åkesson; Isam Atroshi
Journal:  Acta Orthop       Date:  2019-09-10       Impact factor: 3.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.